What We're Reading: Page 333
Industry reads hand-picked by our editors
Jul 26, 2016
-
Stat
An ex-con is taking his debt-ridden, cash-burning biotech public. Why are people investing?
-
Endpoints
Building a bulletproof CAR? Scientists engineer a built-in PD-1 shield
-
PMLive
Boehringer stops Gilotrif head and neck cancer trials
-
The Economic Times
US, Venezuela sink Dr Reddy's; five key takeaways
Jul 25, 2016
Jul 22, 2016
Jul 21, 2016
Jul 20, 2016
Jul 19, 2016
Jul 18, 2016
-
Financial Times
Biotech dives into Sardinia gene pool for secret of long life
-
MIT Technology Review
The White House Is Pushing Precision Medicine, but It Won’t Happen for Years
-
Bloomberg
Apple Scores GlaxoSmithKline Study in Key Test of Health Apps
-
Reuters
China approves use of GSK vaccine Cervarix for cervical cancer
Previous
